Novo Nordisk and Anthropic Partner to Use AI Models and Claude Science in Drug Discovery
Novo Nordisk and Anthropic announced a partnership to apply Anthropic's artificial intelligence models and Claude Science to support drug discovery and development. During intraday trading on September 17, 2026, Chinese innovative drug and CRO-related shares extended gains. Nearshore Protein and Jinshi Asia Pharmaceutical rose by the 20 percent daily limit, while Baihua Pharmaceutical also hit the limit up.
On September 17, 2026, gains in innovative drug and CRO-related shares widened during intraday trading. Nearshore Protein and Jinshi Asia Pharmaceutical rose by the 20 percent daily limit, while Baihua Pharmaceutical also hit the limit up. The moves occurred during the day's trading session and involved innovative drug and CRO-related concepts.
Novo Nordisk and Anthropic announced a partnership under which the two sides will use Anthropic's artificial intelligence models and Claude Science to support drug discovery and development. The collaboration was jointly announced by Novo Nordisk and Anthropic, with the cooperation focused on the drug discovery and development stage.